Aptose Biosciences INC. (APTOF) SEC Filings — 2024
47 SEC filings for Aptose Biosciences INC. (APTOF) in 2024.
Filings
- Aptose Biosciences Inc. Files Definitive Proxy Statement — DEF 14A · Dec 30, 2024
- Aptose Biosciences Inc. Files 8-K Report — 8-K · Dec 19, 2024
- Aptose Biosciences Files 8-K — 8-K · Dec 12, 2024
- Aptose Biosciences Files 8-K — 8-K · Dec 9, 2024
- Aptose Biosciences Files 8-K — 8-K · Dec 3, 2024
- Aptose Biosciences Inc. Files 8-K: Material Agreement — 8-K · Nov 25, 2024
- Aptose Biosciences Files 8-K — 8-K · Nov 22, 2024
- Aptose Biosciences Files 8-K — 8-K · Nov 20, 2024
- Aptose Biosciences INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Aptose Biosciences Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Aptose Biosciences Inc. Files 8-K on Financials — 8-K · Nov 8, 2024
- Aptose Biosciences Files S-1/A Amendment — S-1/A · Oct 31, 2024
- Aptose Biosciences Faces Nasdaq Delisting Warning — 8-K · Oct 4, 2024
- Aptose Biosciences Files 8-K on Shareholder Vote Matters — 8-K · Sep 6, 2024
- Aptose Biosciences Files 8-K — 8-K · Sep 5, 2024
- Aptose Biosciences Enters Material Definitive Agreement — 8-K · Aug 30, 2024
- Aptose Biosciences Files 8-K — 8-K · Aug 15, 2024
- Aptose Biosciences Inc. Files 8-K — 8-K · Aug 8, 2024
- Aptose Biosciences Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Aptose Biosciences Files S-1 for Stock Offering — S-1 · Aug 2, 2024
- Aptose Biosciences Files 8-K with Exhibits — 8-K · Jul 26, 2024
- Aptose Biosciences Faces Nasdaq Delisting Warning — 8-K · Jul 19, 2024
- Aptose Biosciences Files Definitive Proxy Statement — DEF 14A · Jul 17, 2024
- 180 Life Sciences to Acquire Aptose Biosciences — 8-K · Jun 20, 2024
- Aptose Biosciences Files 8-K — 8-K · Jun 14, 2024
- Aptose Biosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 3, 2024
- Aptose Biosciences to be Acquired by RTW Investments Affiliate — 8-K · Jun 3, 2024
- Aptose Biosciences Terminates Material Agreement — 8-K · May 31, 2024
- Aptose Biosciences Inc. files Definitive Proxy Statement for June 18, 2024 Annual Meeting — DEF 14A · May 15, 2024
- Aptose Biosciences Files 8-K on Financials — 8-K · May 14, 2024
- Aptose Biosciences Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Aptose Biosciences Files 8-K — 8-K · May 6, 2024
- Aptose Biosciences Files 8-K: Material Agreement & Officer Changes — 8-K · May 1, 2024
- Aptose Biosciences Inc. Files Amended 10-K for Fiscal Year Ended December 31, 2023 — 10-K/A · Apr 29, 2024
- Hanmi Pharma Amends Stake in Aptose Biosciences — SC 13D/A · Apr 26, 2024
- Aptose Biosciences Inc. Files 8-K — 8-K · Apr 26, 2024
- Aptose Biosciences 8-K: Delisting Notice & Financials — 8-K · Apr 5, 2024
- Aptose Biosciences Files 8-K on Financials — 8-K · Mar 26, 2024
- Aptose Biosciences Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- Aptose Biosciences Files 8-K — 8-K · Mar 18, 2024
- Aptose Biosciences Faces Delisting Concerns — 8-K · Mar 1, 2024
- Aptose Biosciences INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Hanmi Pharma Amends Aptose Biosciences 13D Filing — SC 13D/A · Feb 5, 2024
- Aptose Biosciences Files Routine 8-K on Jan 31, 2024 — 8-K · Jan 31, 2024
- Aptose Biosciences Launches New $50M ATM Offering, Terminates Old One — 8-K · Jan 30, 2024
- Aptose Biosciences Files Routine 8-K for Disclosure Compliance — 8-K · Jan 26, 2024
- Aptose Biosciences Inc. Files Amendment to Registration Statement — S-1/A · Jan 22, 2024